文献速递肝肾功能剂量调整抗菌药物管理治疗药物监测与药物基因组学

危重症患者 augmented renal clearance:系统综述

Augmented Renal Clearance in Critically Ill Patients: A Systematic Review.
PubMed 文献 · Clin Pharmacokinet · 2018-01-01

本系统综述汇总危重症患者 augmented renal clearance(ARC,定义为肌酐清除率>130 mL/min/1.73 m2,最好经尿测定)的证据。ARC 在危重症患者中占 20-65%,年轻、多发伤和病情较轻为危险因素;ARC 与抗菌药物血浆浓度低于治疗水平相关,但对临床结局及其他药物药代动力学的影响尚不明确。

要点

  • ARC 定义为 CrCl>130 mL/min/1.73 m2,最好经尿测定,数学估算常低估 CrCl。
  • ARC 在危重症患者中占 20-65%,年轻、多发伤、病情较轻为危险因素。
  • ARC 与抗菌药物血浆浓度低于治疗水平相关,需关注剂量调整。

核心结论

  • ARC 是危重症患者中普遍存在的现象,尤其见于年轻人,尿 CrCl 是最佳诊断方法。
  • ARC 增加肾脏药物清除,对某些抗菌药物血浆浓度有明确影响,但对临床结局及其他药物药代动力学的影响尚未明确。
  • 需要开展研究以对 ARC 进行分期并制定特定剂量指南。

研究设计与样本

  • 系统综述,纳入所有提供危重症患者 ARC 信息的原始研究,按 PRISMA 指南报告。

主要发现

  • ARC 在危重症患者中占 20-65%。
  • 年轻、多发伤和病情较轻被确定为 ARC 的危险因素。
  • ARC 与抗菌药物血浆浓度低于治疗水平一致相关。

关键数值与推荐

  • ARC 定义为肌酐清除率(CrCl)>130 mL/min/1.73 m2,最好经尿测定。

临床怎么用

  • 临床应关注危重症患者 ARC 风险,尤其年轻、多发伤、病情较轻者,尿 CrCl 优于数学估算。
  • 对 ARC 患者使用抗菌药物时需警惕标准剂量导致的血浆浓度低于治疗水平。

局限性

  • ARC 对临床结局的影响尚未明确。
  • ARC 对其他类型药物药代动力学的影响尚未明确。
  • 需要进一步研究以对 ARC 进行分期并制定特定剂量指南。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Traditionally, renal function in critically ill patients has been assessed to identify renal dysfunction, and dose adjustment is generally accepted in such a context. Nevertheless, augmented renal clearance (ARC) is a less well-studied phenomenon that could lead to faster elimination of drugs, resulting in subtherapeutic concentrations and poorer clinical outcomes when standard dosage guidelines are followed. OBJECTIVE: The aim of this systematic review was to gather and summarise all the available evidence on ARC in critically ill patients, including its definition, underlying mechanisms, epidemiology, diagnosis and impact on both drug pharmacokinetics and clinical outcomes. METHOD: A systematic review was conducted to include all the original studies that provided information on ARC in critically ill patients, and is reported following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. RESULTS: Augmented renal clearance, defined as a creatinine clearance (CrCl) > 130 mL/min/1.73 m2, preferably measured in urine, is present in 20-65% of critically ill patients. Younger age, polytrauma and lower severity illness have been identified as risk factors. An influence of ARC on antimicrobial pharmacokinetics has been observed, with ARC consistently being associated with subtherapeutic antibiotic plasma concentrations. CONCLUSION: ARC is a prevalent condition in critically ill patients, especially in young people, with urinary CrCl being the best diagnostic method because mathematical estimates tend to underestimate CrCl. ARC increases renal drug elimination and has a clear influence on certain antimicrobial plasma levels, but is yet to define its impact on clinical outcomes and on pharmacokinetics of other types of drugs. Research on the need to stage ARC and establish specific dosing guidelines is warranted.

来源:Clin Pharmacokinet,查看原文。版权归原作者所有。

引用

  1. Bilbao-Meseguer I, Rodríguez-Gascón A, Barrasa H, et al. Augmented Renal Clearance in Critically Ill Patients: A Systematic Review. Clin Pharmacokinet. 2018. PMID: 29441476. doi:10.1007/s40262-018-0636-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。